edrophonium has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 5 studies
Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.
Excerpt | Relevance | Reference |
---|---|---|
" In the 12 patients with structural heart disease (including two with arrhythmogenic right ventricular dysplasia), adenosine (260 to 550 microg/kg) failed to slow or terminate VT." | 3.70 | Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects. ( Lerman, BB; Markowitz, SM; Mittal, S; Slotwiner, D; Stein, KM, 1999) |
"The most common form of idiopathic ventricular tachycardia (VT) is repetitive monomorphic VT (RMVT), which is characterized by frequent ventricular ectopy and salvos of nonsustained VT with intervening sinus rhythm." | 1.29 | Mechanism of repetitive monomorphic ventricular tachycardia. ( Battleman, DS; Bei, D; Catanzaro, D; Engelstein, ED; Lerman, BB; Lippman, N; Stein, K, 1995) |
"Reentrant ventricular tachycardia (VT) is known to be insensitive to the nucleoside adenosine." | 1.29 | Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects. ( Lerman, BB, 1993) |
"His ventricular tachycardia was sensitive to adenosine triphosphate, edrophonium, verapamil, and Valsalva's maneuver." | 1.29 | A case of adenosine-sensitive ventricular tachycardia in a very elderly male. ( Betsuyaku, T; Hirao, N; Kitabatake, A; Nakano, N; Sakurai, M; Takano, H; Yoshida, I; Yotsukura, A, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hachiya, H | 1 |
Aonuma, K | 1 |
Yamauchi, Y | 1 |
Sekiguchi, Y | 1 |
Iesaka, Y | 1 |
Lerman, BB | 3 |
Stein, K | 1 |
Engelstein, ED | 1 |
Battleman, DS | 1 |
Lippman, N | 1 |
Bei, D | 1 |
Catanzaro, D | 1 |
Betsuyaku, T | 1 |
Takano, H | 1 |
Hirao, N | 1 |
Nakano, N | 1 |
Yoshida, I | 1 |
Yotsukura, A | 1 |
Sakurai, M | 1 |
Kitabatake, A | 1 |
Stein, KM | 1 |
Markowitz, SM | 1 |
Mittal, S | 1 |
Slotwiner, D | 1 |
5 other studies available for edrophonium and Atrioventricular Nodal Re-Entrant Tachycardia
Article | Year |
---|---|
Edrophonium-induced right ventricular outflow tract tachycardia.
Topics: Adult; Aged; Cholinesterase Inhibitors; Edrophonium; Female; Humans; Male; Middle Aged; Tachycardia, | 2005 |
Mechanism of repetitive monomorphic ventricular tachycardia.
Topics: Adenosine; Adult; Base Sequence; Catheter Ablation; Cyclic AMP; Edrophonium; Electrophysiology; Fema | 1995 |
Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects.
Topics: Acetylcholine; Adenosine; Adolescent; Adult; Aged; Aminophylline; Catecholamines; Chemoreceptor Cell | 1993 |
A case of adenosine-sensitive ventricular tachycardia in a very elderly male.
Topics: Adenosine; Adenosine Triphosphate; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Edrophonium; Ele | 1996 |
Catecholamine facilitated reentrant ventricular tachycardia: uncoupling of adenosine's antiadrenergic effects.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular | 1999 |